Found: 20
Select item for more details and to access through your institution.
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 12, p. 1877, doi. 10.1038/leu.2011.165
- By:
- Publication type:
- Article
Anaplastic large cell lymphoma: the current state of play from a European prospective as presented at the second annual meeting of the European Research Initiative on ALCL, 27-28 June 2011.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Exposure to tungsten induces DNA damage and apoptosis in developing B lymphocytes.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 12, p. 1834, doi. 10.1038/leu.2011.161
- By:
- Publication type:
- Article
Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Impact of TP53 mutation and 17p deletion in mantle cell lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- Letter
The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 12, p. 1891, doi. 10.1038/leu.2011.175
- By:
- Publication type:
- Article
Gene expression profiling in the leukemic stem cell-enriched CD34<sup>+</sup> fraction identifies target genes that predict prognosis in normal karyotype AML.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 12, p. 1825, doi. 10.1038/leu.2011.172
- By:
- Publication type:
- Article
Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 12, p. 1815, doi. 10.1038/leu.2011.158
- By:
- Publication type:
- Article
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Eμ/miR-125b transgenic mice develop lethal B-cell malignancies.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice.
- Published in:
- 2011
- By:
- Publication type:
- journal article
In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 12, p. 1797, doi. 10.1038/leu.2011.169
- By:
- Publication type:
- Article
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.
- Published in:
- 2011
- By:
- Publication type:
- Letter